John Jacobs
Fortune : 3 M $ au 30/06/2026
Fortune : 3 M $ au 30/06/2026
Mr. John C.
Jacobs is a President, Chief Executive Officer & Director at Novavax, Inc. He is on the Board of Directors at Novavax, Inc. and Life Sciences Pennsylvania.
Mr. Jacobs was previously employed as a President & Chief Executive Officer by Harmony Biosciences LLC, a President, Chief Executive Officer & Director by Harmony Biosciences Holdings, Inc., and a Senior VP & GM-Respiratory Business Unit by Teva Pharmaceutical Industries Ltd. He received his undergraduate degree from State University of New York College at Plattsburgh and an MBA from State University of New York at Binghamton.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVAVAX, INC. 0,19% | 23/04/2026 | 306 559 ( 0,19% ) | 3 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NOVAVAX, INC. | Directeur Général | 23/01/2023 |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Directeur/Membre du Conseil | 06/05/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Directeur Général | 23/01/2023 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur Général | 06/01/2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/10/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
State University of New York College at Plattsburgh
State University of New York College at Plattsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Binghamton
State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national